APA

Liao Y., Asakura M., Takashima S., Ogai A., Asano Y., Shintani Y., Minamino T., Asanuma H., Sanada S., Kim J., Kitamura S., Tomoike H., Hori M. & Kitakaze M. (20050208). Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. : Circulation.

Chicago

Liao Yulin, Asakura Masanori, Takashima Seiji, Ogai Akiko, Asano Yoshihiro, Shintani Yasunori, Minamino Tetsuo, Asanuma Hiroshi, Sanada Shoji, Kim Jiyoong, Kitamura Soichiro, Tomoike Hitonobu, Hori Masatsugu and Kitakaze Masafumi. 20050208. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. : Circulation.

Harvard

Liao Y., Asakura M., Takashima S., Ogai A., Asano Y., Shintani Y., Minamino T., Asanuma H., Sanada S., Kim J., Kitamura S., Tomoike H., Hori M. and Kitakaze M. (20050208). Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. : Circulation.

MLA

Liao Yulin, Asakura Masanori, Takashima Seiji, Ogai Akiko, Asano Yoshihiro, Shintani Yasunori, Minamino Tetsuo, Asanuma Hiroshi, Sanada Shoji, Kim Jiyoong, Kitamura Soichiro, Tomoike Hitonobu, Hori Masatsugu and Kitakaze Masafumi. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. : Circulation. 20050208.